Cargando…
CD46 splice variant enhances translation of specific mRNAs linked to an aggressive tumor cell phenotype in bladder cancer
CD46 is well known to be involved in diverse biological processes. Although several splice variants of CD46 have been identified, little is known about the contribution of alternative splicing to its tumorigenic functions. In this study, we found that exclusion of CD46 exon 13 is significantly incre...
Autores principales: | Zeng, Jin, Xu, Hua, Huang, Chunhua, Sun, Yi, Xiao, Haibing, Yu, Gan, Zhou, Hui, Zhang, Yangjun, Yao, Weimin, Xiao, Wei, Hu, Junhui, Wu, Lily, Xing, Jinchun, Wang, Tao, Chen, Zhiqiang, Ye, Zhangqun, Chen, Ke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7972933/ https://www.ncbi.nlm.nih.gov/pubmed/33767911 http://dx.doi.org/10.1016/j.omtn.2021.02.019 |
Ejemplares similares
-
HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395
por: Sun, Guoliang, et al.
Publicado: (2020) -
Retraction Note: HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395
por: Sun, Guoliang, et al.
Publicado: (2023) -
Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma
por: Yan, Libin, et al.
Publicado: (2019) -
Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma: Erratum
por: Yan, Libin, et al.
Publicado: (2022) -
Junction plakoglobin regulates and destabilizes HIF2α to inhibit tumorigenesis of renal cell carcinoma
por: Chen, Ke, et al.
Publicado: (2021)